Dental Care Clinics in Sunland, CA Accepting Medicare
7 Dental Care Clinics found. Showing 1 - 7
 Nina Fridman Dds Inc Dentist Medicare: Not Enrolled in Medicare Practice Location: 8522 Foothill Blvd, Sunland, CA 91040 Phone: 213-864-2503 |
Shirvani, Michael Dental Corporation Dentist Medicare: Not Enrolled in Medicare Practice Location: 8654 Foothill Blvd, #b, Sunland, CA 91040 Phone: 818-951-7299 |
Oscar J. Carbonell Dds A Professional Corporation Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 8654 Foothill Blvd Ste B, Sunland, CA 91040 Phone: 818-323-1615 |
Shahen Rostamian Dds Inc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 8120 Foothill Blvd, Sunland, CA 91040 Phone: 818-224-4224 Fax: 818-224-4442 |
Sunland Family Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 8522 Foothill Blvd, Sunland, CA 91040 Phone: 818-352-8888 Fax: 818-352-4451 |
Sunland Dental Care Dentist Medicare: Not Enrolled in Medicare Practice Location: 7902 Foothill Blvd, Sunland, CA 91040 Phone: 818-353-5520 Fax: 818-353-4387 |
Pars Dental Group Dentist Medicare: Not Enrolled in Medicare Practice Location: 7902 Foothill Blvd, Sunland, CA 91040 Phone: 818-353-5520 |
News Archive
Education and screening of pregnant women recommended for prevention of Fetal Alcohol Spectrum Disorder
Featured in the August edition of the Journal of Obstetrics and Gynaecology Canada is a new consensus clinical practice guideline which recommends that screening for alcohol consumption be done periodically for all pregnant women and women of child-bearing age.
AstraZeneca, Impax enter license agreement to commercialize Zomig in the U.S.
Impax Pharmaceuticals, the branded products business unit of Impax Laboratories, Inc., announced today that it has licensed from AstraZeneca the exclusive United States (U.S.) commercial rights to Zomig (zolmitriptan) tablet, orally disintegrating tablet, and nasal spray formulations.
Insurance status linked to patient safety, quality of care for patients with brain tumors
Patients that are on Medicaid or uninsured have higher rates of reportable patient safety and quality of care issues during hospitalization for brain tumors, reports a study in the March issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
Researchers identify mutant traits in mouse for many human disease genes
About one-third of all genes in the mammalian genome are essential for life. An international, multi-institutional research collaboration identified, for the first time, mutant traits in the mouse for 52 human disease genes, which significantly contributes to the understanding of the genetic bases for some human diseases, including cardiovascular defects, spina bifida, and metabolic disorders, among many others. The study was published this week in Nature.
Alnylam presents interim data from ALN-VSP02 Phase I trial for liver cancer at ASCO 2010
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today preliminary clinical data from its ongoing Phase I trial with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement.
› Verified 3 days ago